Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

Translated title of the contribution: Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

J.E. Arends, A.I.M. Hoepelman, N.M. Nanlohy, F.J.P. Höppener, K.R. Hirsch, J.G. Park, D. van Baarle

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionLow doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.
Original languageUndefined/Unknown
Pages (from-to)959-966
Number of pages8
JournalApoptosis
Volume16
Issue number9
Publication statusPublished - 2011

Cite this